MC38 tumor‐derived exosomes with IL‐12 overexpression and TGF‐β1 knockdown enhanced DC‐based therapy and inhibited tumor growth via the activation of Th1.[191] To abrogate the impact of immune checkpoints on anti‐tumor immunity, Huang et al. Here, TGFB1 is linked to neoplasm.